[Clinical aspects in the prevention of antibody formation with anti-D-immunoglobulin].
D000917:Antibody Formation; D004899:Erythroblastosis, Fetal / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D005319:Fetal Hemoglobin; D005331:Fetomaternal Transfusion; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000276:immunology / Q000517:prevention & control*; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000627:therapeutic use*
D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins; D005319:Fetal Hemoglobin
Klinische Aspekte der Prophylaxe mit Anti-D-Immunglobulin.